PROVIDER FILE · The briefing room

altRx Review: Monthly Prices, Renewal Rules and the Limits of “Cancel Anytime”

altRx advertises compounded semaglutide at $89 a month and compounded tirzepatide at $149 a month. Its public terms make the enrollment decision more complicated: recurring billing, conflicting cancellation deadlines and substantial refund exclusions deserve attention before payment.

The most important number in an altRx enrollment decision may not be the advertised monthly price. It may be the number of hours remaining before the next charge. The company’s cancellation policy requires at least 72 hours’ notice, while its terms describe a 48-hour deadline. That disagreement matters because the cancellation policy says a request received too late triggers another nonrefundable billing cycle. “Cancel anytime,” the phrase displayed on the homepage, does not resolve which deadline a customer should rely on.

altRx markets a telehealth weight-management membership connecting adults with clinical professionals and independent pharmacies. Its public documentation provides useful details about medication options, payment responsibilities and fulfillment, but leaves important checkout terms unspecified. This review examines those documents as consulted October 19, 2026, with particular attention to what enrollment authorizes, who owes which service and what happens when treatment or participation ends. It is a documentary assessment, not an evaluation based on purchasing treatment or independently verifying clinical performance.

At a glance

Advertised compounded-medication prices
The compounded GLP-1 page displays $89/month and the compounded GLP-1/GIP page $149/month, each for a prescription-only multi-dose vial. Membership materials identify compounded semaglutide and compounded tirzepatide as injectable options.
Sources: [4] [15] [6]
Conflicting cancellation deadlines
The cancellation policy requires notice at least 72 hours before the next billing date; the terms describe cancellation up to 48 hours before monthly processing.
Sources: [14] [7]
Separate service responsibilities
altRx handles nonclinical functions; OpenLoop operates the platform, and medical services are attributed to OpenLoop Healthcare Partners, PC and affiliated practices.
Sources: [7] [12]
Cancellation is not a refund
The policy says cancellation stops future billing only. Multi-month plans carry a full-term commitment without prorated refunds for unused services or unshipped medication.
Sources: [14]
Self-pay with reimbursement restrictions
Insurance is not required, but the terms also prohibit seeking or receiving reimbursement from federal, state or private healthcare payors for services or products obtained through the service.
Sources: [15] [7]

Start with the renewal deadline, not the slogan

altRx’s terms authorize automatic charges at the recurring intervals disclosed during checkout, continuing unless and until the subscription is canceled. That makes the checkout disclosure consequential: a monthly-looking product page does not, by itself, establish the complete payment schedule. Before authorizing payment, a prospective member should retain the selected plan, next billing date and cancellation instructions. The public documentation does not establish the minimum commitment attached to every advertised monthly price.

The more restrictive cancellation policy requires a request to be received at least 72 hours before the next billing date. Inside that window, it says another cycle will be charged, that charge is nonrefundable and cancellation takes effect at the subsequent cycle. Separately, the terms allow cancellation up to 48 hours before monthly processing through care@altrx.com, the platform or a preformatted email. These are materially different instructions, not interchangeable descriptions.

A practical preparation step is to obtain written clarification before enrolling and, if canceling, submit the request earlier than the longer published deadline while retaining confirmation. That does not settle which document governs; it reduces avoidable timing uncertainty. The broader distinction explained in our guide to cancellation notice and renewal dates is especially relevant here: the date a request is sent, the date it is received and the date a new charge processes may not be identical.

Contract provisions to reconcile before authorizing recurring payment
IssueWhat the documents sayWhat to confirm
RenewalAutomatic charges at checkout-disclosed intervalsExact interval and next charge date
Cancellation notice72 hours in the policy; 48 hours in the termsWhich deadline applies to the selected plan
Multi-month purchaseFull-term commitment; no prorated refundTotal price and duration before paying
Medical ineligibilityUnused current-term portion refunded after service deductionsHow completed services are valued
Damaged or incorrect itemsPharmacy replacement is the sole stated remedyEvidence and reporting process
Sources: [7] [14] [12]

What the monthly prices actually document

The product pages display $89 per month for the compounded GLP-1 option and $149 per month for the compounded GLP-1/GIP option. Both identify prescription-only multi-dose vials; membership materials name compounded semaglutide and compounded tirzepatide, respectively. The safety pages identify both as subcutaneous injections. These are not documented prices for branded Wegovy, Ozempic or Zepbound, even though the homepage also lists those injectable products. Their prices and individual availability are not established in the consulted documentation.

The membership description includes telehealth consultations, a personalized care plan, prescription fulfillment when appropriate and shipping. The compounded GLP-1 product page also advertises syringes, needles and alcohol swabs in a complete kit. The homepage says there are no membership fees and no price hike, despite describing the service elsewhere as a membership and subscription. That marketing language should not replace confirmation of the actual checkout amount, included services and future billing terms.

The refund policy separately describes discounted multi-month or bundled plans purchased in exchange for a full-term commitment. Public documentation does not establish their total prices, specific discounts, medication quantities per shipment or the relationship between those bundles and the displayed monthly prices. Flexible payment options are mentioned without details. Our explanation of monthly prices versus payment commitments provides a useful framework, but only altRx’s selected checkout offer can resolve those provider-specific unknowns.

Refund rights are narrower than stopping participation

The general policy makes a sharp distinction between ending participation and recovering money. Failure to finish an intake form, attend or complete a consultation, or fill or accept a prescription does not create a refund entitlement. Cancellation stops future billing rather than reversing amounts already paid. This means that beginning a paid subscription and then deciding not to proceed is not treated like abandoning the free assessment before enrollment.

For multi-month plans, the exclusions are especially broad. The policy says there is no refund or credit for an unused month, unused service, undelivered or unshipped medication, or any remaining part of the term. It also says the purchase price will not be prorated or reduced. A package therefore represents more than a convenient display of a monthly equivalent: the policy expressly links its discount to a full-term commitment.

There is a medical-ineligibility exception. If a provider determines that the member is not clinically eligible, the subscription is canceled and the unused portion of the current term is refunded after deducting services already rendered, including consultations or provider reviews. That is not a promise of a complete refund. Prospective members should ask how those deductions are priced; the general principles in our guide to refund boundaries and exclusions help distinguish that exception from a blanket money-back guarantee.

Sources: [14]

The company selling access is not the clinical practice

The terms describe altRx and OpenLoop as separate legal entities. altRx supplies nonclinical content, marketing, customer support and administrative services; OpenLoop operates the platform; independent licensed healthcare professionals provide care. The homepage’s legal language attributes clinical evaluation and prescribing to OpenLoop Healthcare Partners, PC and affiliated professional practices. Accordingly, a complaint about a charge and a question about treatment may require different people, even when both begin in the same patient portal.

That allocation deserves attention because the homepage also refers to “on-staff licensed clinicians,” while its legal disclosures describe independent clinical practices and state that altRx does not employ healthcare professionals or deliver medical services. The terms expressly say altRx is not a medical group, pharmacy or healthcare provider. Those descriptions should not be flattened into an assumption that the brand itself supplies every service advertised under its name.

There is also a corporate-name inconsistency: a safety page identifies Altrx, Inc., while the terms’ copyright-notice instructions use altRx LLC at the same Boca Raton address. This does not establish wrongdoing, but it is a reasonable reason to request the contracting entity’s exact name on receipts and agreements. Our guide to platform, clinician and pharmacy responsibilities explains why keeping these roles separate is useful when asking who can correct an administrative, clinical or dispensing problem.

Sources: [7] [12] [9]

Enrollment buys a process, not a guaranteed prescription

altRx advertises a free, two-minute assessment with no obligation. The form asks for height, weight and goal weight and explains that the information helps calculate BMI and build a treatment profile. Completing that web assessment does not itself create a provider-patient relationship with altRx. The important transition is from free screening to any paid subscription: prospective members should understand when payment authorization begins and which services can become nonrefundable before a prescribing decision.

A licensed provider reviews the health evaluation and may conduct the consultation through live video or asynchronous review, depending on the provider and applicable state telehealth rules. Prescribing remains solely the provider’s decision and is never guaranteed. Enrollment requires age 18 or older; the semaglutide safety page additionally states that its product is not for people 75 or older. That restriction should not be generalized into an identical rule for every option on the website.

The provider’s review includes medical history, current medications and contraindications, with the site specifically naming personal or family history of medullary thyroid carcinoma and MEN2. The terms advertise service throughout all 50 states and Washington, DC, but clinician availability and prescribing authority vary by state. The homepage says the assigned provider will be licensed in the patient’s state of residence. These are provider disclosures, not independently verified licensing findings or a promise that every applicant can obtain treatment.

Sources: [12] [5] [15] [11] [7]

Pharmacy fulfillment creates another set of responsibilities

If treatment is appropriate, the prescription goes to a licensed pharmacy for fulfillment. altRx lists RedRock Pharmacy in Utah, Health Warehouse in Kentucky, Precision Medicine in New York and Triad Rx in Alabama in its pharmacy network. It describes compounding partners as independently owned, state-licensed 503A pharmacies and says altRx does not manufacture or compound medication. Those statements identify the advertised arrangement; the consulted documentation does not independently verify licenses, lot testing or which pharmacy will serve an individual member.

The terms permit a patient to ask for an issued prescription to be sent to a pharmacy of their choice rather than a pharmacy accessible through the service. That option does not establish that outside-pharmacy charges remain included in the advertised membership price. Before choosing it, the useful contractual question is how prescription transfer affects medication payment, shipping, cancellation and any unused subscription benefits. Public documentation does not settle those consequences for a particular order.

The FAQ estimates approximately four to five business days for processing and delivery combined after treatment is found appropriate; it does not give a separate guaranteed clinical-review timeline. Terms warn that pharmacy processing, verification, carriers, weather and holidays can affect shipping. For damaged or incorrect items, the policy makes pharmacy replacement the sole remedy, not a refund. Separately, FDA advises not using injectable GLP-1 medication that arrives warm or insufficiently refrigerated and contacting the provider or dispensing pharmacy.

Sources: [15] [7] [12] [14] [1]

Self-pay, support and information-sharing terms

The FAQ describes altRx as self-pay and says insurance is not required. Its terms go further: neither the patient nor the participating entities may seek or receive reimbursement from federal, state or private healthcare payors for products or services provided through the service. This is more restrictive than simply saying the company does not bill insurance. Homepage HSA/FSA advertising is not accompanied in the consulted documentation by eligibility conditions, receipt requirements or a detailed payment procedure.

For help, the contact page recommends the patient portal as the fastest route for account, prescription or health questions. General nonurgent inquiries may take up to 48 hours, and the published phone number is +1 607-601-6969. The homepage advertises 24/7 access plus unlimited appointments, messaging and support, but does not establish a guaranteed clinical response time. The availability claim should therefore be read separately from promises about how quickly a clinician will answer.

Privacy responsibilities also span different entities. altRx’s terms say it is not a HIPAA covered entity, while a separate HIPAA notice describes rights to inspect and copy medical and billing records and request corrections. Its consumer health data policy says such data may be shared with third-party providers to advertise and market services. Before completing intake, readers should examine which entity receives their information and which notice applies, rather than assuming one privacy framework covers every interaction.

Ongoing care and evidence do not follow automatically from renewal

altRx describes reassessment if a member’s BMI falls below 25, with possible adjustment, maintenance, pause or discontinuation depending on the clinician’s judgment. That is not a promise of automatic continuation. Nor do the public documents explain how a membership pause affects charges, shipments or renewal. A member facing a clinical change should therefore ask separately about the care decision and the subscription decision; the available documentation does not show that one necessarily updates the other.

The site acknowledges that its compounded versions are not FDA approved and have not been independently evaluated by FDA for safety, efficacy or quality. Its product page also advertises USP 797 standards and purity and potency testing, but those are provider claims rather than independent verification here. FDA recommends compounded drugs when an individual’s medical needs cannot be met by an approved drug, with a prescription and state-licensed pharmacy. Nonapproval alone does not establish clinical inequivalence.

Contract clarity cannot establish treatment outcomes. Clinical studies of specific products do not validate altRx’s service, its compounded preparations or an individual’s expected results. FDA also reports measurement and administration errors involving compounded medication; instructions should be clarified with the prescriber or pharmacist, not reconstructed from an article. These considerations make the quality of the consultation and follow-up important alongside price, while leaving the central contractual question intact: what services remain owed when clinical needs or participation change?

Sources: [15] [4] [1] [2] [3]

Questions & answers

Can I cancel altRx whenever I want?

You can request cancellation, but timing affects the next charge. The policy requires receipt at least 72 hours before billing, while the terms describe a 48-hour deadline before monthly processing. Ask altRx to reconcile that discrepancy in writing. Cancellation does not refund prior payments or erase an expressly purchased multi-month commitment.

Sources: [14] [7]
Will altRx refund me if a clinician decides I am ineligible?

Its policy provides a refund for the unused portion of the current term after subtracting services already rendered, such as consultations or provider reviews. That is narrower than a full refund. Before paying, ask what those services cost and how the unused portion would be calculated for your selected plan.

Sources: [14]
Do the $89 and $149 prices include medication and shipping?

The corresponding compounded-product pages display those monthly prices, and the membership description includes prescription fulfillment when appropriate and shipping, along with consultations and a care plan. However, the public documents do not establish medication quantity per shipment or every plan commitment. Confirm the selected product, total charge, billing interval and inclusions at checkout.

Sources: [4] [15]
Can I submit altRx charges to my insurance afterward?

The terms say neither patients nor participating entities may seek or receive reimbursement from federal, state or private healthcare payors for products or services obtained through the service. Do not interpret “insurance not required” as permission to submit a later reimbursement claim. Request clarification before enrolling if reimbursement is essential to your budget.

Sources: [7] [15]
Who should handle a delivery or medication problem?

The patient portal is altRx’s recommended first contact for prescription and health questions, while the dispensing pharmacy handles fulfillment and the stated replacement remedy for damaged or incorrect items. If an injectable arrives warm or insufficiently refrigerated, FDA advises not using it and contacting the provider or pharmacy. The advertised shipping estimate is not a delivery guarantee.

Sources: [8] [14] [7] [1]
Does altRx guarantee a prescription after the free assessment?

No. The free assessment is preliminary, and completing it does not create a provider-patient relationship with altRx. A licensed provider conducts the clinical evaluation and retains sole prescribing discretion. Enrollment is limited to adults, and additional product-specific restrictions apply. A paid subscription should not be understood as purchasing a guaranteed prescription.

Sources: [12] [5] [15] [11]

Our assessment

altRx documents recognizable service roles, advertised compounded-medication prices, included shipping and a medical-ineligibility refund exception. Those disclosures give prospective members useful starting points. The weaker area is the boundary between marketing simplicity and contractual commitment: conflicting cancellation deadlines, broad nonrefundability, full-term bundled obligations and reimbursement restrictions materially affect the enrollment decision. Before paying, obtain the exact plan total, renewal date, applicable notice deadline, service-deduction amounts and consequences of a clinical pause in writing. The service should be evaluated as a recurring self-pay arrangement involving separate administrative, clinical and pharmacy entities—not merely as a monthly medication price. Clear answers to those questions would make comparison more meaningful without establishing clinical suitability or guaranteeing treatment results.

Sources & documentation

Public materials consulted October 19, 2026. Provider statements are attributed claims, not independently verified clinical outcomes. Terms can change; obtain a current written quote.

  1. FDA concerns with unapproved GLP-1 drugs used for weight loss ↗
  2. Wilding et al. (2021): STEP 1 semaglutide trial ↗
  3. Jastreboff et al. (2022): SURMOUNT-1 tirzepatide trial ↗
  4. altRx — products/compounded semaglutide ↗
  5. altRx — v3/consultation ↗
  6. altRx — about ↗
  7. altRx — v3/terms and conditions ↗
  8. altRx — contact ↗
  9. altRx — important safety information/compounded tirzepatide ↗
  10. altRx — v3/consumer health data privacy policy ↗
  11. altRx — important safety information/compounded semaglutide ↗
  12. altRx — official website ↗
  13. altRx — v3/privacy practices ↗
  14. altRx — v3/refund cancellation policy ↗
  15. altRx — products/compounded tirzepatide ↗

Continue reading